WARF THERAPEUTICS: A GROWING PORTFOLIO
WARF Therapeutics combines industry caliber drug discovery capabilities with strategic partnerships and internal medicinal chemistry expertise, enabling us to interrogate novel validated targets discovered at UW-Madison.
By applying resources and stage gate milestones, we will move programs toward optimized novel molecules, with the goal of demonstrating in vivo proof of concept and support for the therapeutic hypothesis. We will advance suitably de-risked programs to clinical testing through a variety of mechanisms including licensing, investment partnerships and startup companies.
Our portfolio consists of programs that have achieved a high degree of preclinical validation, span a spectrum of therapeutic areas and are focused on improving the lives of patients with unmet medical needs.
click to view a larger version of the portfolio